Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roederer

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Immunity|October 24, 2001
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissuesD A Eckstein, M L Penn, Y D Korin, et al.
Nature Medicine|June 17, 1999
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsP P Lee, C Yee, P A Savage, et al.
International Immunology|November 5, 1999
Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseasesD K Mitra, S C De Rosa, A Luke, et al.
Bone Marrow Transplantation|November 25, 2014
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CYA Roberto, L Castagna, S Gandolfi, et al.
European Journal of Clinical Investigation|October 13, 2000
N-acetylcysteine replenishes glutathione in HIV infectionS C De Rosa, M D Zaretsky, J G Dubs, et al.
Clinical and Experimental Immunology|October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaK Jones, L Wockner, R M Brennan, et al.
Vaccine|November 2, 2010
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adultsJ E Ledgerwood, P Costner, N Desai, et al.
Immunity|July 31, 2012
T cell assays and MIATA: the essential minimum for maximum impactC M Britten, S Janetzki, L H Butterfield, et al.
Scientific Reports|December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorM Giel-Moloney, M Esteban, B H Oakes, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Immunity|October 24, 2001
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissuesD A Eckstein, M L Penn, Y D Korin, et al.
Nature Medicine|June 17, 1999
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsP P Lee, C Yee, P A Savage, et al.
International Immunology|November 5, 1999
Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseasesD K Mitra, S C De Rosa, A Luke, et al.
Bone Marrow Transplantation|November 25, 2014
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CYA Roberto, L Castagna, S Gandolfi, et al.
European Journal of Clinical Investigation|October 13, 2000
N-acetylcysteine replenishes glutathione in HIV infectionS C De Rosa, M D Zaretsky, J G Dubs, et al.
Clinical and Experimental Immunology|October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaK Jones, L Wockner, R M Brennan, et al.
Vaccine|November 2, 2010
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adultsJ E Ledgerwood, P Costner, N Desai, et al.
Immunity|July 31, 2012
T cell assays and MIATA: the essential minimum for maximum impactC M Britten, S Janetzki, L H Butterfield, et al.
Scientific Reports|December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorM Giel-Moloney, M Esteban, B H Oakes, et al.
Pageof 7